AP
BSX icon

AHL Partners’s Boston Scientific BSX Stock Holding History

AHL Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$4.39M Buy
177,037
+81,617
+86% +$2.25M 0.07% 519
2017
Q3 		$2.78M Sell
95,420
-4,539
-5% -$125K 0.05% 566
2017
Q2 		$2.77M Buy
99,959
+39,455
+65% +$1.05M 0.06% 542
2017
Q1 		$1.5M Buy
60,504
+35,647
+143% +$867K 0.03% 690
2016
Q4 		$538K Sell
24,857
-22,744
-48% -$496K 0.02% 808
2016
Q3 		$1.13M Buy
47,601
+12,937
+37% +$309K 0.04% 559
2016
Q2 		$810K Buy
34,664
+18,773
+118% +$406K 0.04% 492
2016
Q1 		$299K Buy
15,891
+1,555
+11% +$27.3K 0.02% 673
2015
Q4 		$264K Sell
14,336
-6,554
-31% -$117K 0.02% 642
2015
Q3 		$343K Buy
20,890
+3,074
+17% +$52.5K 0.05% 521
2015
Q2 		$315K Buy
17,816
+3,488
+24% +$62.3K 0.01% 767
2015
Q1 		$254K Sell
14,328
-102,988
-88% -$1.63M 0.01% 738
2014
Q4 		$1.55M Buy
117,316
+38,938
+50% +$498K 0.08% 529
2014
Q3 		$926K Buy
+78,378
New +$987K 0.07% 365

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

AHL Partners's BSX Position: Q4 2017 in Review

AHL Partners increased its Boston Scientific (BSX) stake by 86% in Q4 2017, buying an estimated $2.25M and bringing the position to 177,037 shares worth $4.39M. The position accounts for 0.07% of the portfolio, ranked #519.

AHL Partners first reported a position in BSX in Q3 2014 and has held it in 14 quarters since. 632 funds tracked by Wall St. Rank hold BSX as of Q4 2017.

  • AHL Partners held 177,037 shares of Boston Scientific worth $4.39M as of Q4 2017.
  • AHL Partners bought 81,617 Boston Scientific shares in Q4 2017, an estimated $2.25M.
  • Boston Scientific made up 0.07% of AHL Partners's portfolio in Q4 2017, its #519 holding.
  • AHL Partners first reported a position in Boston Scientific in Q3 2014 and has held it in 14 quarters since.
  • 632 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.